A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

NCT05347576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2Diabetes

Interventions

DRUG: CKD-393(2)
DRUG: CKD-501, D759, D150, D029

Sponsor

Chong Kun Dang Pharmaceutical